Gallus BioPharmaceuticals has completed a second expansion of its Process Development (PD) facility at its headquarters in St. Louis, MO. This expansion provides additional laboratory space and state-of-the-art instrumentation to support Gallus’ growth. Mark R. Bamforth, Gallus’ president and chief executive officer, commented, “Following the acquisition of the Laureate Biopharma business last September, Gallus is now supporting five of the top 15 pharmaceutical companies and a growing number o...